Bo Xiao

34PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Food properties (incl. characteristics and health benefits)Cancer geneticsMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Oct 11, 2026
A dual-site oral nanovaccine programs anti-colorectal tumor immunity from small intestinal priming to large intestinal boosting.

|May 11, 2026
Zwitterionic Lipid Nanotherapeutics from Mulberry for Oral Treatment of Diabetic Colitis.

|Nov 11, 2025
Pathology-Driven Design of a Biomimetic Ferromagnetic Nanomedicine for Dual-Mode Treatment of Ulcerative Colitis and Colitis-Associated Colorectal Cancer.

Shengsheng Liu, Baoyi Li, Qiang Yang

|Sep 26, 2025
Reinforced plant-derived lipid nanoparticles for oral precise epigenome editing in colonic diseases.

Qiang Gao, Yunxia Gao, Yingui Cao

|Jun 23, 2025
Systemic IFN-I Synergizes with Topical TLR7/8 Agonists to Suppress Metastatic Tumors.

Haiting Xu, Chenghui Wang, Bo Xiao

|Jun 13, 2025
Oral Plant-Derived Nanomedicines Mitigate Acetaminophen-Induced Liver Injury by Modulating the Gut-Liver Axis and Intestinal Microbiota Metabolism.

Li Chen, Menghang Zu, Yingui Cao

Pageof 6

Frequent Collaborators

7 joint publications

Subhas C Kundu

3 joint publications

Rui L Reis

3 joint publications

Jiucun Chen

2 joint publications

Changming Li